Inno-Gene SA
WSE:IGN
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Salesforce Inc
NYSE:CRM
|
Technology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
UK |
Endava PLC
NYSE:DAVA
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Citigroup Inc
NYSE:C
|
Banking
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
|
US |
Fortinet Inc
NASDAQ:FTNT
|
Technology
|
|
US |
Intel Corp
NASDAQ:INTC
|
Semiconductors
|
|
US |
Starbucks Corp
NASDAQ:SBUX
|
Hotels, Restaurants & Leisure
|
|
US |
Copart Inc
NASDAQ:CPRT
|
Commercial Services & Supplies
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
N/A
N/A
|
Price Target |
|
We'll email you a reminder when the closing price reaches PLN.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Salesforce Inc
NYSE:CRM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Endava PLC
NYSE:DAVA
|
UK | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
Coca-Cola Co
NYSE:KO
|
US | |
Citigroup Inc
NYSE:C
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US | |
Fortinet Inc
NASDAQ:FTNT
|
US | |
Intel Corp
NASDAQ:INTC
|
US | |
Starbucks Corp
NASDAQ:SBUX
|
US | |
Copart Inc
NASDAQ:CPRT
|
US |
This alert will be permanently deleted.
Inno-Gene SA
Operating Expenses
Inno-Gene SA
Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
I
|
Inno-Gene SA
WSE:IGN
|
Operating Expenses
-zł2.4m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-3%
|
|
M
|
Medicofarma Biotech SA
WSE:MDB
|
Operating Expenses
-zł3m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
R
|
Ryvu Therapeutics SA
WSE:RVU
|
Operating Expenses
-zł145.9m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-49%
|
CAGR 10-Years
-34%
|
|
S
|
Selvita SA
WSE:SLV
|
Operating Expenses
-zł207.6m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Inno-Gene SA
Glance View
Inno Gene SA engages in the management of startup biotechnology companies. The company is headquartered in Poznan, Woj. Wielkopolskie. The company went IPO on 2011-02-08. Inno-Gene SA’s portfolio comprises of Centrum Badan DNA Sp. z o.o., a company that provides services in the field of genetic medical diagnostics, including microbiological diagnosis of infection and the suitability of human congenital diseases using tests performed on DNA microarray technology. On March 22, 2013, the Company established a new subsidiary, Centrum Edukacji Bio-Medycznej Sp. z o.o. On April 11, 2013, the Company established two new indirect subsidiaries, Genomix Sp. z o.o. and Madgenetix Sp. z o.o. In addition, it operates through VitainSillica Sp z o o.
See Also
What is Inno-Gene SA's Operating Expenses?
Operating Expenses
-2.4m
PLN
Based on the financial report for Jun 30, 2024, Inno-Gene SA's Operating Expenses amounts to -2.4m PLN.
What is Inno-Gene SA's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-3%
Over the last year, the Operating Expenses growth was 76%. The average annual Operating Expenses growth rates for Inno-Gene SA have been 6% over the past three years , -14% over the past five years , and -3% over the past ten years .